Low interest rates and favorable tax environments are stoking the fires of takeovers, with about a quarter of big groups now on the lookout for targets in the next 12 months, a study found last week.
“Plans for transformational acquisitions are accelerating,” the survey by consultancy Ernst and Young (EY) concluded.
The pharmaceutical sector has led the way so far this year with deals worth US$150 billion, according to consultancy Dealogic, and that does not include a failed bid worth US$117 billion by US firm Pfizer for British-Swedish group AstraZeneca.
On Friday, a bid worth US$46 billion by US drugs laboratory AbbVie was rejected by Shire Pharmaceuticals, which is listed in London and New York, but based in Dublin.
On Wednesday, US group Valeant launched a hostile bid of US$53.5 billion for Allergan.
Much of this is driven by a need to grow and cut costs to counter the expiration of some patents on high-earning drugs, analysts say.
The survey assessment by EY backs up comments from analysts for some time that ultra-low interest rates by several leading central banks are one of the main factors reigniting interest in takeovers.
Other forces are at work as well: During the financial crisis that began in 2008 and the subsequent eurozone debt crisis, many big companies restructured their businesses and hoarded cash. They did not have sufficient confidence in the outlook to invest, even by borrowing cheap money being pushed at the banking system by some central banks.
However, now many businesses are gaining confidence in the recovery and are looking to expand by buying other businesses, which can offer a faster route to growth than setting up new operations, and may be less risky.
EY interviewed 1,600 executives in companies in 54 countries. It found that the number of big groups willing to launch takeovers of than US$500 million had doubled in 12 months to 27 percent of the total. Those willing to do deals of more than US$1 billion had doubled to 12 percent.
Their willingness to take on debt to finance deals was the highest for five years.
Many companies are under pressure from aggressive shareholders to cut costs, which could make company boards highly selective in looking at targets.
“After a prolonged financial crisis and merger-and-acquisition [M&A] market malaise, companies and boards are opting for quality rather than quantity,” said the head of M&A activity in France for EY, Rudy Cohen Scali.
Recently US and European companies have led M&A activity, but emerging companies could begin to play a significant role, led by China and India, the report said.
“The top five investment destinations balance emerging markets such as India and China with a continued focus on mature markets such as the US, UK and Germany,” it found.
The EY report said that “30 percent of executives perceive global political instability to be the greatest economic risk.”
Henderson Global Investors’ data last month showed that in the first quarter of the year, big companies had raised dividend payouts to shareholders by nearly a third.
With the crises fading, and despite sluggish growth “all over the markets there is liquidity waiting to be used,” Paris-based Barclays Bourse portfolio manager Renaud Murail said then.
“American companies have accumulated huge warchests,” he said.
At investment group Amundi, global head of equities Romain Boscher said at the time: “The wave of mergers and acquisitions is just beginning.”
Cohen Scali said in the EY report: “The fundamentals for high-value deal-making are very favorable... However, the complexity of the challenge facing executives today means M&A is more measured.”
Michael Hewson, chief market analyst at CMC Markets UK, contested suggestions that the upsurge of M&A activity reflects renewed confidence in some parts of the global economy, saying that one driving factor was a search by US companies to use their piles of cash abroad in a way which would not attract tax if the money were sent to headquarters in the US.
Pfizer’s failed attempt to acquire AstraZeneca “was the most high-profile attempt” to use cash, he said.
With many stock markets close to record highs, boardrooms were considering buying back shares, or returning reserves to shareholders — citing Rolls-Royce this week as the latest example of this.
Attempts by US group General Electric to buy a large part of French engineering group Alstom could also be motivated in part by the fact that it had US$57 billion outside the US at the end of last year, he said.
This raised questions about “the value and reasons behind these deals,” Hewson said.
CAUTIOUS RECOVERY: While the manufacturing sector returned to growth amid the US-China trade truce, firms remain wary as uncertainty clouds the outlook, the CIER said The local manufacturing sector returned to expansion last month, as the official purchasing managers’ index (PMI) rose 2.1 points to 51.0, driven by a temporary easing in US-China trade tensions, the Chung-Hua Institution for Economic Research (CIER, 中華經濟研究院) said yesterday. The PMI gauges the health of the manufacturing industry, with readings above 50 indicating expansion and those below 50 signaling contraction. “Firms are not as pessimistic as they were in April, but they remain far from optimistic,” CIER president Lien Hsien-ming (連賢明) said at a news conference. The full impact of US tariff decisions is unlikely to become clear until later this month
GROWING CONCERN: Some senior Trump administration officials opposed the UAE expansion over fears that another TSMC project could jeopardize its US investment Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) is evaluating building an advanced production facility in the United Arab Emirates (UAE) and has discussed the possibility with officials in US President Donald Trump’s administration, people familiar with the matter said, in a potentially major bet on the Middle East that would only come to fruition with Washington’s approval. The company has had multiple meetings in the past few months with US Special Envoy to the Middle East Steve Witkoff and officials from MGX, an influential investment vehicle overseen by the UAE president’s brother, the people said. The conversations are a continuation of talks that
CHIP DUTIES: TSMC said it voiced its concerns to Washington about tariffs, telling the US commerce department that it wants ‘fair treatment’ to protect its competitiveness Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) yesterday reiterated robust business prospects for this year as strong artificial intelligence (AI) chip demand from Nvidia Corp and other customers would absorb the impacts of US tariffs. “The impact of tariffs would be indirect, as the custom tax is the importers’ responsibility, not the exporters,” TSMC chairman and chief executive officer C.C. Wei (魏哲家) said at the chipmaker’s annual shareholders’ meeting in Hsinchu City. TSMC’s business could be affected if people become reluctant to buy electronics due to inflated prices, Wei said. In addition, the chipmaker has voiced its concern to the US Department of Commerce
STILL LOADED: Last year’s richest person, Quanta Computer Inc chairman Barry Lam, dropped to second place despite an 8 percent increase in his wealth to US$12.6 billion Staff writer, with CNA Daniel Tsai (蔡明忠) and Richard Tsai (蔡明興), the brothers who run Fubon Group (富邦集團), topped the Forbes list of Taiwan’s 50 richest people this year, released on Wednesday in New York. The magazine said that a stronger New Taiwan dollar pushed the combined wealth of Taiwan’s 50 richest people up 13 percent, from US$174 billion to US$197 billion, with 36 of the people on the list seeing their wealth increase. That came as Taiwan’s economy grew 4.6 percent last year, its fastest pace in three years, driven by the strong performance of the semiconductor industry, the magazine said. The Tsai
RSS